Mayo Clinic Minute: What is chimeric antigen receptor T cell remedy
Roughly 635,000 new circumstances of lymphoma have been identified worldwide, in accordance with the World Cancer Research Fund International’s most up-to-date report. Survival charges for aggressive lymphomas have improved considerably because of advances in remedy, equivalent to chimeric antigen receptor-T cell remedy (CAR-T cell remedy).
Dr. Madiha Iqbal, a Mayo Clinic hematologist and oncologist, explains that CAR-T cell remedy is a customized and revolutionary remedy giving hope to sufferers identified with numerous lymphomas.
[FOR YOUTUBE VIDEO DESCRIPTIONS]
FOR THE PUBLIC: More well being and medical information on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: To entry clear and NAT sound variations of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/
Mayo Clinic: https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic
Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic